Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
what is wrong with u *****ing lot . why the hell r u investing in aim shares if u have no idea how the mms and in general how aim works . the mms create a market for themselves .. nothing more nothing less ... at open this share went up about 10 % cos its very good news rns . they can drop a share or up it at their whim . if u believe in the product buy more on the dips or if want to trade sell at 10 % up . its that simple . if tb sells so wot . he is a serial winner and collects his profits as and when he chooses . just as u can . brh in my opinion as a company is superb and its not just about paraytec . this is 1 of many multi baggers . have a look wot brh are involved in re diff interests . if tb can keep up the work re dividends this must be 1 of the best companies on aim to hold shares in . also listen not to the recent posters and look at more knowledgable long term holders who have done all the research .. gla . ps it was about 60 p mid april . if 1 big or more players are announced then paraytec could go massive . then on to the next biggy with brh
("Gunsynd" or the "Company")
New Investment - Anglo Saxony Mining
Gunsynd Plc (AIM: GUN, AQSE: GUN) is pleased to announce that it has invested £125,000 in Anglo Saxony Mining Limited ("ASM"), a public unlisted tin development and exploration company.
The ASM investment was executed on the following terms:
· subscription for 833,333 ordinary shares at 15 pence per share for a total consideration of £125,000;
· following this capital raising ASM will have 135,000,000 (fully diluted) shares in issue for pro-forma equity valuation of £20.25 million;
· Gunsynd's investment is a part of a of £5,000,000 capital raising supported by institutional and high net worth UK, German and Australian investors; and
· funds will be used for resource expansion drilling, resource conversion, metallurgical test work and PFS & Optimisation studies. ASM has ambitions to carry out an IPO during 2021.
About Anglo Saxony Mining Limited
ASM plans to establish sustainable tin production and processing from the Tellerhäuser Mine in Saxony, Germany. The Tellerhäuser Mine has a 50-year mining licence granted in 2020 with final permitting well advanced. The local Erzgebirge area has 800 years of mining history, including the world's oldest School of Mines. The Tellerhäuser mine comes with 150,000m of tunnels and other underground development, approx. 140,000m of historical drilling and 3,000m of channel sampling from past owners of the project. ASM has ambitions to become a sustainable tin producer from a zero-waste mine by carrying out all of its processing and waste to be located in underground voids. The waste material will be stored and treated via water treatment facility in-situ and pumped to a nearby storage plant.
Peter Ruse, a director of Gunsynd, commented: "Gunsynd is pleased to have the opportunity to participate in the financing for ASM - an exciting tin development opportunity in Western Europe. Tin as a commodity has caught the market's attention since late 2020, with prices rising quickly on the back of a fundamental supply-demand mismatch coming out of the COVID-19 pandemic. The Tellerhäuser deposit benefits from extensive mine infrastructure from past investment and exploration expenditure. The deposit sits on the doorstep of numerous German and Austrian tin and zinc smelters in a region with 800 years of active mining operations."
Example of Goods in Transit
ABC International ships $10,000 of merchandise to Aruba Clothiers on November 28. The terms of the delivery are FOB shipping point. Since these terms mean that Aruba takes ownership of the merchandise as soon as it leaves ABC's shipping dock, ABC should record a sale transaction on November 28, and Aruba should record an inventory receipt on the same date.
Assume the same scenario, but the terms of delivery are now FOB destination, and the shipment does not arrive at Aruba's receiving dock until December 2. In this case, the same transactions occur, but on December 2 instead of November 28. Thus, under the FOB destination shipping scenario, ABC does not record a sale transaction until December.
Accounting for Goods in Transit
From a practical perspective, the buyer may not have a procedure in place to record inventory until it arrives at the receiving dock. This causes a problem under FOB shipping point terms, because the shipping entity records the transaction at the point of shipment, and the receiving company does not record receipt until the transaction is recorded at its receiving dock - thus, no one records the inventory while it is in transit from the seller to the buyer.
The delay in recording the receipt of goods by the buyer is not really a problem, as long as the business refrains from also recording the related account payable until such time as it records the related inventory. Otherwise, there will be a mismatch between the asset and related liability.
Example of Goods in Transit
ABC International ships $10,000 of merchandise to Aruba Clothiers on November 28. The terms of the delivery are FOB shipping point. Since these terms mean that Aruba takes ownership of the merchandise as soon as it leaves ABC's shipping dock, ABC should record a sale transaction on November 28, and Aruba should record an inventory receipt on the same date.
Assume the same scenario, but the terms of delivery are now FOB destination, and the shipment does not arrive at Aruba's receiving dock until December 2. In this case, the same transactions occur, but on December 2 instead of November 28. Thus, under the FOB destination shipping scenario, ABC does not record a sale transaction until December.
Accounting for Goods in Transit
From a practical perspective, the buyer may not have a procedure in place to record inventory until it arrives at the receiving dock. This causes a problem under FOB shipping point terms, because the shipping entity records the transaction at the point of shipment, and the receiving company does not record receipt until the transaction is recorded at its receiving dock - thus, no one records the inventory while it is in transit from the seller to the buyer.
The delay in recording the receipt of goods by the buyer is not really a problem, as long as the business refrains from also recording the related account payable until such time as it records the related inventory. Otherwise, there will be a mismatch between the asset and related liability.
(The "Company" or "SYME")
Inventory "in transit" monetisation: business acquisition
Supply@ME Capital plc, the innovative fintech platform which provides the Inventory Monetisation service to manufacturing and trading companies, is pleased to announce that it has signed Heads of Terms ("HoT") for the acquisition of a leading FinTech-powered commodities trade enabler, focused on SMEs, based in Singapore.
The acquisition will allow SYME's Platform to complete its global offering, by monetising inventory (in particular, commodities) "in-transit". Not least, it would generate a number of attractive synergy benefits for SYME from both a funding and customer origination perspective.
Following the signing of the HoT and completion of Due Diligence, SYME expects to complete the acquisition within the next month.
A further announcement will be made on completion of the transaction.
The Company also plans to issue a Trading Update before the end of March.
Notes
Supply@ME enables businesses to generate cashflow, without incurring debt, by monetising their existing stock. Before a business has found an end-customer for its inventory, the Supply@ME platform enables them to sell ("monetise") their stock and receive cash immediately to boost their working capital. The Supply@ME service enables strong companies to improve their working capital cycle. SYME does not monetise inventory for companies in financial difficulty or with inventory that they are struggling to sell.
all newbys dont be disheartned about the share price drop . its a positive . next few months i forsee a buy out by a major player . always look at the late trades to evaluate where the serious money is going . the sp is at this moment being held back . the mms dictate the price of a share and in aim its basically corrupt what they can get away with . have a look at prem mining today today to see how the mms create a false market . gla
Correction: the following announcement replaces the notification released on 03 March 2021 at 4.29 p.m. under RNS number 0830R.
The original RNS incorrectly stated Trevor Brown's resulting percentage of enlarged issued share as 25.55 and resulting interest in Ordinary Shares capital as 9,788,288. The correct numbers are 23.09 and 8,843,288, respectively.
Braveheart Investment Group plc
("Braveheart" or the "Company")
Exercise of Employee Share Options, Block Admission Application, Issue of Equity and
Total Voting Rights
Braveheart Investment Group (AIM: BRH) announces that it has received notices of exercise of employee share options by Trevor Brown, a director of the Company, over a total of 1,200,000 new ordinary shares of 2p each (the "New Shares") as follows:
Following the issue of these shares Trevor Brown will have the following interest in the Company's Ordinary Shares:
Name of Director
Role
Number of New Shares
Resulting interest in Ordinary Shares
Resulting percentage of enlarged issued share capital
Trevor Brown
CEO
1,200,000
8,843,288
23.09
Application will be made for the New Shares to be admitted to trading on AIM and it is expected that admission will take place on or around 9 March 2021 ("Admission"). The New Shares will rank pari passu in all respects with the Company's existing ordinary shares.
Block Admission Application
Braveheart further announces that an application has been made to the London Stock Exchange for a block admission to trading on AIM of 1,150,000 new ordinary shares of 2p each in the Company ("New Ordinary Shares") (the "Block Admission"). The Block Admission is being made for any issue and allotment of New Ordinary Shares arising from the exercise of options issued pursuant to the award of share options to directors, employees and consultants announced on 17 December 2020, after excluding the above options exercised by Trevor Brown.
Upon issue, the New Ordinary Shares will be issued credited as fully paid and rank pari passu in all respects with the existing ordinary shares of the Company. In accordance with rule 29 of the AIM Rules for Companies, the number of New Ordinary Shares issued and allotted under the Block Admission arrangement will be announced every six months.
It is expected that the Block Admission will become effective on or around 9 March 2021.
Total Voting Rights
Upon Admission, the issued share capital of the Company will consist of 38,297,451 ordinary shares of 2p each. The Company does not hold any shares in treasury. Therefore, the total number of voting rights in the Company from Admission will be 38,297,451. This figure may be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.
("Braveheart" or the "Group")
Further update re Paraytec Limited
Further to the announcements on 29 January 2021, Braveheart Investment Group plc (AIM: BRH), is pleased to provide an update concerning progress to develop a COVID-19 test that Paraytec Limited ("Paraytec" or the "Company") is working on in conjunction with the University of Sheffield.
Testing of the first 500 samples being provided by Sheffield Hospitals Trust has been a key focus of the Paraytec team's work in the last month. The clinical sample pipeline is now fully operational.
Samples are being processed and subjected to analysis using Paraytec's photonics-based detection system. The average time to acquire test results is currently less than 120 seconds, a market-leading value. The laboratory trials data confirm the performance of Paraytec's photonics-based test in identifying patients with an infectious viral load within the acceptable range specified by MHRA.
The current gold standard for estimation of viral load continues to be laboratory-based PCR tests. However, these detect viral RNA levels and not necessarily the presence of infectious virions, which means that many patients test positive, long after they are no longer infectious. Paraytec has thus adopted an additional comparator test developed by the University of Sheffield, to verify the presence of intact virus particles. This involves ultracentrifugation and high-resolution fluorescence microscopy to independently verify the presence of virions in clinical samples.
In parallel to the sample processing described above, the Paraytec team has been using isolated lab-grown virus to optimise the operational sensitivity of its instrument for the detection of pre-symptomatic and early-stage symptomatic virus levels. It believes it will be able to confirm, within a period of four weeks, a lower limit of detection of 1,000 virions per millilitre of sample, also a market-leading value.
Paraytec will complete additional analysis of samples in the clinical pipeline in order to acquire robust statistical data and prepare the detailed technical specification required by regulators and producers. The team believes that the high speed and high sensitivity of its test may enable the undertaking of multiplexed "matrix" testing. Matrix testing combines samples from multiple people for simultaneous analysis, such that 20 parallel tests can yield individual results for up to one hundred people. Such a test would be very helpful to the successful operation of large events, like sports or music festivals.
Paraytec will now progress to a prospective clinical validation with a larger number of patient samples and seek to obtain a CE mark for the test. Depending on location, the prospective clinical trial (where individual patient outcomes are monitored over time) is expected to take two months to complete and a further update is expected to be made by the end of April 2021. As previously stated, Paraytec are se
Supply@ME Capital plc(The "Company" or "SYME")Update on Restoration of Listing Further to the announcement made by the Company on 4 February 2021, SYME issues the following statement regarding the restoration of its Listing on the Standard List of the London Stock Exchange. The Company successfully addressed the technical DTR breach regarding the timing of the publication of its financial statements on 29 January. SYME has since been in regular communication with the FCA in support of the regulatory steps and due process required for the lifting of the temporary suspension. The Company is aware that this has taken longer than expected. However, the temporary suspension has not impacted SYME's inventory funding routes and the related commercial activities which are continuing simultaneously across the several operating geographies. The Company notes that the timetable for the relisting and resumption of share dealings is outside of its control. It will keep shareholders updated regarding progress as it is made. Contacts
("Braveheart" or the "Group")
Further update re Paraytec Limited
Further to the announcements on 18 and 24 December 2020, Braveheart Investment Group plc (AIM: BRH), is pleased to provide an update concerning progress to develop a COVID-19 test that Paraytec Limited is working on in conjunction with the University of Sheffield.
Delivery of the 500 clinical samples from Sheffield Hospitals Trust were delayed due to unprecedented pressure on hospital services responding to COVID-19. However, Paraytec has reported to Braveheart that the pipeline of clinical samples is now fully operational and additional staff have been recruited to process samples for performance assessment.
The Paraytec and University of Sheffield team will use these samples to set the test operational parameters so that it attains or exceeds the recommended guidelines for upper limits on false positive and negative tests set by the Medical Health Regulatory Authority. Results from this phase of clinical testing are now expected by the end of February.
To minimise the effects of this delay, Paraytec has brought forward scheduled work, using isolated lab-grown virus to optimise the operational sensitivity (sometimes called 'lower limit of detection') of our instrument for the detection of pre-symptomatic and early-stage symptomatic levels of virus. Paraytec's target is to detect less than 1000 virions per millilitre of sample, which would represent a market leading performance, if achieved. By re-arranging the workflows Paraytec does not believe that there will be any overall delay to the development programme.
It is already clear that current vaccines are not 100% effective and the infection risk is being compounded by the emergence of new strains of the COVID-19 virus. Braveheart has been advised that the Paraytec and University of Sheffield team believes there is, and will continue to be, a significant and ongoing demand for rapid tests for the early detection of the virus, to protect communities and the world's economy.
Braveheart and Paraytec remain committed to developing a test which achieves the performance parameters specified by the Medical Health Regulatory Authority and delivers a test result in five minutes. Detection tests show that Paraytec's aptamer based viral capture system completely traps target material in 300 seconds or less, confirming that its test platform is on target to deliver a test result within a five-minute timeframe, subject to successful completion of the clinical sampling tests.
Prof Carl Smythe, who leads the University of Sheffield team, commented, "We are very pleased with the rapid performance of our sample capture device. Together with the analytical sensitivity and speed of the optical system, we are on track to deliver a robust test that will support the level of infection control required globally."
Trevor Brown, CEO of Braveheart, commented "Though slightly delayed, the clinical sample pipeline is now fully
i bought into eua in 2019 at 3p . i researched it re other large mine sales and came to the conclusion its worth min £1 a share . i now sitting on a freeby having sold half . i have now decided to become a full time trader and have invested in 3 other stocks which i think u folks should look into . they r about to go very big in my opinion . brh . braveheart . remote monitoring systems rms and supply me capital syme . gla
26-Jan-21 16:15:42 2.825 400,000 Sell* 2.80 2.90 11.30k O
25-Jan-21 08:01:34 3.07 977,199 Buy* 2.80 2.90 30.00k O
25-Jan-21 08:27:31 2.95 1,133,838 Buy* 2.80 2.90 33.45k O
25-Jan-21 08:46:43 2.90 852,979 Buy* 2.80 2.90 24.74k O
25-Jan-21 16:10:25 2.8517 1,034,072 Buy* 2.80 2.90 29.49k O
25-Jan-21 08:40:28 2.93 835,870 Buy* 2.80 2.90 24.49k O
25-Jan-21 08:54:37 2.8689 1,545,839 Buy* 2.80 2.90 44.35k O
25-Jan-21 14:20:20 2.85 1,049,295 Buy* 2.80 2.90 29.90k O
25-Jan-21 15:38:39 2.839 1,000,000 Sell* 2.80 2.90 28.39k O
25-Jan-21 08:55:20 2.81 958,729 Sell* 2.80 2.90 26.94k O
25-Jan-21 14:52:15 2.84 886,248 Sell* 2.80 2.90 25.17k O
26-Jan-21 17:08:00 2.85 542,996 Buy* 2.80 2.90 15.48k
Eurasia Mining Plc
Update on Formal Sale Process
Eurasia Mining Plc ("Eurasia" or the "Company"), the palladium, platinum, rhodium, iridium and gold producing company, is pleased to provide an update on the Formal Sale Process initiated by the Company under the UK Takeover Code.
Since launching the Formal Sale Process on 1 July 2020, Eurasia and its advisers have engaged with a wide range of parties, and have to date received non-binding offers in respect of both a possible acquisition of the Company as well as other transaction structures.
Progress to date has been slower than expected reflecting the complexity of the process, involving several parties and structures, as well as external factors including COVID-19 related travel restrictions, and more recently delays resulting from western and Russian holiday periods. Notwithstanding these factors, discussions regarding proceeding to binding proposals are continuing. Until a transaction is finally concluded there can be no certainty that a transaction will occur or on what terms.
Further announcements will be made when appropriate.
A copy of this announcement is also available on Eurasia's website at:
https://www.eurasiamining.co.uk/investors/news-announcements.
Supply@ME Capital plc, the innovative fintech platform which provides the Inventory Monetisation© service to manufacturing and trading companies, is pleased to provide the following update on its first securitisation issuance, co-arranged and distributed by StormHarbour Securities LLP.
SYME and StormHarbour have now successfully completed the legal documentation, process definition and operating structure for its repeatable and scalable securitised investment product. The eligible Client Companies are ready to implement the inventory monetisation process and their financial advisory teams (including external auditors numbering among them two of the Big4[1] audit firms) have approved the structure and derecognition accounting treatment of the inventory monetisation transaction.
In the Update of 30 November 2020, SYME stated that one of the objectives of this period of work on the Open-Funding securitisation model has been to create a new Inventory Monetisation asset class that reflects best practice principles in the securitisation market. The completion of this stage now enables SYME to programme a series of securitisation issuances that, together with cornerstone investment from its Captive Bank operation, should provide access to a deeper, ongoing pool of capital, facilitating the provision of the inventory monetisation service across several active geographies.
Further steps towards the implementation of this wider securitisation programme with the Inventory Funder include negotiations regarding:
· a move from the "single transaction" to an Inventory Monetisation programme for the whole of 2021; SYME expects that this "size-increase" combined with a more flexible funding structure would allow the Platform to monetise its entire current portfolio of eligible Client Companies across a series of securitisation rounds;
· a potential minority equity investment by the Inventory Funder in the capital of the Company; and
· given the funding capacity of the Quadrivio Group, a widening of discussions relating to their involvement in all securitisation issuances, via the Captive Bank.
Early in the New Year, the eligible Client Companies will receive a formal, confidential communication from SYME disclosing the identity of the Inventory Funder and the time-table to execute their individual inventory monetisation transactions. Shortly thereafter, the Company intends to disclose to the market the identity of the Inventory Funder, the key features of the Inventory Monetisation programme and the targeted positive revenue impact for SYME.
The Company expects to make these disclosures within the next month once the Inventory Funder confirms its release from the non-disclosure agreement or as required by market disclosure regulations.
Supply@ME enables businesses to generate cashflow, without incurring debt, by monetising their existing stock. Before a business has found an end-customer for its inventory, the Supply@ME
(The "Company" or "SYME")
New Investment in SYME
Supply@ME Capital plc, the innovative fintech platform which provides the Inventory Monetisation© service to manufacturing and trading companies, is pleased to provide the following update regarding its expanding shareholder base.
Five professional investors (the "New Investors") have, acquired, in aggregate a 12.2% shareholding in the Company, further diversifying and strengthening the Company's investor base. Their combined shareholdings, comprising 4 billion ordinary shares, were acquired following completion of the transactions detailed below, which are aimed at simplifying the Company's ownership structure going forward:
· the purchase by 1AF2 S.r.l of 4.2bn SYME ordinary shares from IWEP Ltd at 0.0048 GBP;
· a merger between 1AF2 S.r.l. and the AvantGarde Group S.p.A.. The merged company will be named "the AvantGarde Group";
· the disposal of all of Orchestra Group's SYME ordinary shares to the newly formed AvantGarde Group; and
· the sale of 4.0bn SYME ordinary shares by the AvantGarde Group to the New Investors at 0.0048 GBP based on the performance of the Company.
Following completion of the transactions, the shareholdings of each of the three parties will be as follows:
· the AvantGarde Group SpA (post-merger*) 38,9%
· The New Investors** 12.2%
· IWEP Ltd*** <3%
The AvantGarde Group and the New Investors may, in due course, propose a new director to the Company to add to the experience of the existing board. The New Investors may also purchase further shares directly through the market.
Welcoming the New Shareholders, Alessandro Zamboni, CEO of SYME, commented:
"These transactions have enabled us to increase the diversity and number of committed, professional investors on the Company's Share Register and will undoubtedly help to raise our investment profile".
*Mr. Zamboni will be the beneficial owner of the AvantGarde Group, post-merger. The percentage stated does not include the 17.99% of SYME shares related to the collateral transferred in accordance with the three stock-lending transactions announced on 29 July 2020. At the end of this stock-lending transaction or on the repayment date (in July 2022), the collateral will be returned to the Group in shares or cash, at the choice of the borrower
** New Investors' combined holdings (five independent investors)
*** IWEP Ltd is a company controlled by Non-Executive Chairman Dominic White. Following the transaction and a reorganisation of his holdings, Mr White will hold less than 3% of the ordinary shares of the Company
17 December 2020
Braveheart Investment Group plc
("Braveheart" or the "Group")
Director/PDMR Shareholding
Notification of Transactions of Persons Discharging Managerial Responsibilities (PDMRs)
At the Annual General Meeting held on 8 September 2020, shareholders approved the creation of a share option scheme in order to provide a long term incentive plan for Directors, Employees and consultants of the Group, including those Strategic Investments where Braveheart owns 50% or more of the issued share capital. A new plan, which is limited so that the number of shares awarded under the plan will not exceed 20% of the then issued share capital of the Company, has now been put in place ("the Share Option Plan").
Braveheart announces that, pursuant to the Share Option Plan, Trevor Brown and Vivian Hallam, both directors of Braveheart and persons discharging managerial responsibilities ("PDMR") of the Company have been granted options over 1,200,000 and 500,000 Ordinary Shares of 2 pence each in the Group ("Ordinary Shares"), respectively, at an exercise price of 17p per share, being the closing mid-market price on 16 December 2020. The options vest with immediate effect and are exercisable up to 16 December 2030.
A further 650,000 options over Ordinary Shares have been granted to employees and consultants of the Group, on the same terms as above.
Details of the transactions can be found in the Notification of Dealing Forms below.